Takeda Cashed In From Delay Of Generic IBS Drug, Jury Told
By Carolyn Muyskens · May 14, 2026, 5:52 PM EDT
Drug buyers urged a Massachusetts federal jury on Thursday to find that Takeda Pharmaceuticals conspired with another drugmaker to keep a generic version of anticonstipation drug Amitiza off the market in...
To view the full article, register now.